Categories: Wire Stories

Asia Pacific Limited-Service Restaurants Market Report 2022 – LSR Adapted Well to Take-Away and Home Deliver Orders During Pandemic – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Limited-Service Restaurants in Asia Pacific” report has been added to ResearchAndMarkets.com’s offering.

After sales at limited-service restaurants (LSR) declined in 2020, negatively impacted by measures taken to contain the spread of Coronavirus (COVID-19), they were back recording positive growth in 2021. Even in 2020, LSR was one of the better performers, given the ability of most players in this channel to adapt to increased takeaway and home delivery orders. Further positive growth is expected over the coming years.

The Limited-Service Restaurants in Asia Pacific global briefing offers an insight into to the size and shape of the Consumer Foodservice market, highlights buzz topics, emerging geographies, categories and trends as well as pressing industry issues and white spaces. It identifies the leading operators and brands, offers strategic analysis of key factors influencing the operating environment – be they economic/lifestyle influences, new foodservice concepts, outlet locations, menu innovation or format development.

The entire industry is considered, including both chained and independent operators. Forecasts illustrate how the market is set to change and what is the criteria for success.

Product coverage: Consumer Foodservice by Location, Consumer Foodservice by Type.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Key Topics Covered:

  • Introduction
  • Regional Overview
  • Leading Companies and Brands
  • Forecast Projections
  • Country Snapshots

Key Report Benefits:

  • Get a detailed picture of the Consumer Foodservice market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

For more information about this report visit https://www.researchandmarkets.com/r/4bl7aw

Source: Euromonitor International

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Alex

Recent Posts

Fabrinet Announces Third Quarter Fiscal Year 2024 Financial Results

Exceeds Guidance Ranges with Record Revenue and Net Income Per Share BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN),…

3 hours ago

South Korea Data Center Market Investment Analysis Report 2024-2029: Opportunities in IT, Electrical, Mechanical Infrastructure, General Construction, and Tier Standards – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "South Korea Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report…

6 hours ago

Revitalized “Marco Polo” Opera Celebrates Sino-Italian Ties at Guangzhou Opera House

GUANGZHOU, China--(BUSINESS WIRE)--On May 3rd and 4th, the Guangzhou Opera House welcomed nearly 200 international…

7 hours ago

BrainChip Earns Australian Patent for Improved Spiking Neural Network

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first…

7 hours ago

NetApp Appoints Market Growth and Revenue Operations Leader, Dallas Olson to Chief Commercial Officer Role

SAN JOSE, Calif.--(BUSINESS WIRE)--NetApp (NASDAQ: NTAP), the intelligent data infrastructure company, today announced Dallas Olson…

8 hours ago

Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies

BEIJING--(BUSINESS WIRE)--#Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on…

9 hours ago